JPS61194008A - Cosmetic - Google Patents

Cosmetic

Info

Publication number
JPS61194008A
JPS61194008A JP60035595A JP3559585A JPS61194008A JP S61194008 A JPS61194008 A JP S61194008A JP 60035595 A JP60035595 A JP 60035595A JP 3559585 A JP3559585 A JP 3559585A JP S61194008 A JPS61194008 A JP S61194008A
Authority
JP
Japan
Prior art keywords
ascorbic acid
juice
sponge gourd
cosmetic
loofah
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60035595A
Other languages
Japanese (ja)
Other versions
JPH0118044B2 (en
Inventor
Junko Kurakake
倉掛 順子
Kenzo Ito
建三 伊藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP60035595A priority Critical patent/JPS61194008A/en
Publication of JPS61194008A publication Critical patent/JPS61194008A/en
Publication of JPH0118044B2 publication Critical patent/JPH0118044B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Abstract

PURPOSE:A cosmetic having improved beautify effects capable of enhancing ability of liquid juice of sponge gourd to inhibit tyrosinase action and improving remarkably staining freckle, dark complexion, etc., obtained by using both the juice of sponge gourd and L-ascorbic acid or its ester. CONSTITUTION:A cosmetic using both juice of sponge gourd oozed from fruit of stems of sponge gourd (the juice has inhibitory effects on tyrosinase action to form melanin from tyrosine and one or more selected from a group consisting of vitamin C, namely, ascorbic acid and its ester in a weight ratio of 1:20-20:1. The amount of the juice of sponge gourd blended is >=0.0001wt% based on total amounts of external preparation for the sin effects.

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は美白効果が著しく改良された新規な化粧料に関
する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a novel cosmetic with significantly improved whitening effect.

[従来の技術]および[発明が解決しようとする問題点
] 皮膚美白剤を配合した化粧料はしみそばかすなどの原因
となる日焼した皮膚などを美白する為に主として使用さ
れており、化粧料のなかでも消費者の関心が非常に高い
ものである。
[Prior art] and [Problems to be solved by the invention] Cosmetics containing skin whitening agents are mainly used to whiten sunburned skin that causes spots and freckles. Of these, consumers are particularly interested.

アスコルビン酸はチロシンからメラニンを生成するチロ
シナーゼの作用を阻害し、又、生成している濃色酸化型
メラニンを淡色還元型メラニンに戻す作用を有し、皮膚
の美白化、しみ、そばかす、黒皮症、肝斑等の治療、改
善に有効な化合物であることは周知であるが、熱や、光
に対して極めて不安にで酸化され易い性質を有し、特に
、水分を含有する化粧料中においては分解し易く、着色
を招き易い。そのためアスコルビン酸を安定化する目的
でアスコルビン酸を高級脂肪酸やりん酸のエステル体と
して配合したり、抗酸化剤もしくは還元剤を使用添加す
ることが提案されているが、アスコルビン酸を安定化す
ればする程、美白効果が薄れ、配合量を増せば皮膚刺激
が出現するといった問題点があった。
Ascorbic acid inhibits the action of tyrosinase, which produces melanin from tyrosine, and also has the effect of converting the dark oxidized melanin that is being produced into light reduced melanin, resulting in whitening of the skin, age spots, freckles, and black skin. Although it is well known that it is an effective compound for treating and improving melasma, melasma, etc., it is extremely sensitive to heat and light and is easily oxidized, making it particularly difficult to use in cosmetics containing moisture. It is easy to decompose and cause discoloration. Therefore, in order to stabilize ascorbic acid, it has been proposed to blend ascorbic acid as an ester of higher fatty acids or phosphoric acid, or to add antioxidants or reducing agents. The more the product is used, the less the whitening effect becomes, and if the amount of the product is increased, skin irritation may occur.

[問題点゛を解決するための手段] 本発明者等は、このような事情に鑑み、真に優れた美白
効果を有する化粧料を得るべく鋭意研究を重ねた結果、
ヘチマの液汁に、チロシンからメラニンを生成するチロ
シナーゼの作用を阻害する働きがあること、その阻害効
果はL−アスコルビン酸またはその誘導体と併用するこ
とにより増強し、しみ、そばかす、色黒などが著しく改
善されることを見出し、本発明を完成するに至った。
[Means for solving the problem] In view of the above circumstances, the inventors of the present invention have conducted extensive research to obtain cosmetics with truly excellent whitening effects, and as a result, have found that:
Loofah sap has the ability to inhibit the action of tyrosinase, which produces melanin from tyrosine, and its inhibitory effect is enhanced when used in combination with L-ascorbic acid or its derivatives, resulting in noticeable age spots, freckles, and dark skin. The present inventors have discovered that this can be improved, and have completed the present invention.

すなわち、本発明は、L−アスコルビン酸およびそのエ
ステルよりなる群から選ばれた一種又は二種以上と、ヘ
チマの液汁とを含有することを特徴とする化粧料である
That is, the present invention is a cosmetic material containing one or more selected from the group consisting of L-ascorbic acid and esters thereof, and loofah sap.

以下、本発明の構成について詳述する。Hereinafter, the configuration of the present invention will be explained in detail.

本発明で使用するし一アスコルビン酸は、一般にビタミ
ンCといわれ、その強い還元作用により細胞呼吸作用、
酵素賦活作用、膠原形成作用を有し、逅っメラミン還元
作用を有する。又、L−アスコルビン酸エステルとして
は、例えば、L−アスコルビン酸モノステアレート、L
−アスコルビン酸モノパルミテート、L−アスコルビン
酸モノオレート等のL−アスコルビン酸モノアルキルエ
ステル類、L−アスコルビン酸モノリン酸エステル、L
−アスコルビン酸−2−硫酸のようなし一アスコルビン
酸モノエステル訪導体、L−アスコルビン酸ジ支テアレ
ート、L−アスコルビン酸ジパルミテート、L−アスコ
ルビン酸ジオレート等のL−アスコルビン酸モリン酸エ
ステルのようなL−アスコルビン酸ジエステル誘導体、
L−アスコルビン酸トリステアレート、L−アスコルビ
ン酸トリパルミテート、L−アスコルビン酸トリオレー
ト等のトリアルキルエステル類、L−アスコルビン酸ト
リリン酸エステル等のアスコルビン酸トリエステル誘導
体等をあげることがで営る。
Mono-ascorbic acid used in the present invention is generally referred to as vitamin C, and its strong reducing action promotes cellular respiration.
It has an enzyme activation effect, a collagen formation effect, and a melamine reduction effect. In addition, examples of L-ascorbic acid esters include L-ascorbic acid monostearate, L-ascorbic acid monostearate, and L-ascorbic acid monostearate.
- L-ascorbic acid monoalkyl esters such as ascorbic acid monopalmitate, L-ascorbic acid monooleate, L-ascorbic acid monophosphate, L
- Mono-ascorbic acid monoester conductors such as ascorbic acid-2-sulfuric acid, L-ascorbic acid distearate, L-ascorbic acid dipalmitate, L-ascorbic acid dioleate, etc. -ascorbic acid diester derivative,
Commercially available examples include trialkyl esters such as L-ascorbic acid tristearate, L-ascorbic acid tripalmitate, and L-ascorbic acid triolate, and ascorbic acid triester derivatives such as L-ascorbic acid triphosphate. Ru.

本発明の化粧料には上記したし一アスコルビン酸および
そのエステルからな、る群より選ばれた一種又は二種以
上が適宜選択され使用される。
In the cosmetics of the present invention, one or more selected from the group consisting of monoascorbic acid and its esters described above are appropriately selected and used.

L−アスコルビン酸又はL−アスコルビン酸エステルは
、化粧料中に、0.001重量%以上配合すると効果が
あられれ、本発明の効果を発揮するためには10重量%
程度で十分である。
L-ascorbic acid or L-ascorbic acid ester is effective when incorporated in cosmetics at 0.001% by weight or more, and in order to exhibit the effects of the present invention, 10% by weight is required.
It is enough.

本発明に用いるヘチマの液汁とはウリ科ヘチマ属ヘチマ
の果実又は茎から浸出する液汁である。
The sap of loofah used in the present invention is the sap exuded from the fruit or stem of loofah of the family Cucurbitaceae, genus Luffa.

ヘチマは熱帯地方の原産で各地に栽培される1年生の草
本である。夏秋の頃に、黄色の単性孔を開営雄花は総状
、雌花は単文する。果実は長円柱形で網状繊維に富んで
いる。ヘチマから得られる液汁は江戸時代から自然の化
粧水として知られるようにざわやかな芳香と保水作用に
優れ肌をなめらかに清潔に保つ働ぎがある。
Loofah is an annual herb that is native to the tropics and cultivated in many places. In summer and autumn, yellow unisexual pores are opened.Male flowers are raceme and female flowers are simple. The fruit is long cylindrical and rich in reticular fibers. The sap obtained from loofah has been known as a natural lotion since the Edo period, and has a refreshing aroma and excellent water-retaining properties, helping to keep your skin smooth and clean.

本発明のヘチマの液汁の配合量は皮膚外用全量中の0.
0001重量%以上配合すると効果があられれる。
The blending amount of the loofah sap of the present invention is 0.0000% of the total amount for external use on the skin.
If it is blended in an amount of 0,001% by weight or more, the effect will be enhanced.

L−アスコルビン酸又はL−アスコルビン酸エステルと
、ヘチマ抽出物との配合比は重量比で1 : 20−2
0:1が好ましい。
The blending ratio of L-ascorbic acid or L-ascorbic acid ester and loofah extract is 1:20-2 by weight.
0:1 is preferred.

本発明の皮膚外用剤には上記した必須成分の他に通常化
粧料に用いられ配合される他の成分、例えば油分、11
i!潤剤、紫外線吸収剤、酸化防止剤、界面活性剤、防
腐剤、保湿剤、香料、水、アルコール、増粘剤等を必要
に応じて適宜配合することができる。
In addition to the above-mentioned essential ingredients, the skin external preparation of the present invention contains other ingredients that are usually used and blended in cosmetics, such as oil, 11
i! A lubricant, an ultraviolet absorber, an antioxidant, a surfactant, a preservative, a humectant, a fragrance, water, alcohol, a thickener, and the like can be added as appropriate.

次に実施例をあげて本発明をざらに詳細に説明する。本
発明はこれにより限定されるものではない。配合量は重
量%である。
Next, the present invention will be roughly explained in detail with reference to Examples. The present invention is not limited thereby. The blending amount is in weight%.

尚、美白効果は、ドーパから黒−褐色色素メラニンを生
成するチロシナーゼの作用を阻害する割合で示すいわゆ
るチロシナーゼ活性阻害率と、累積塗布による皮膚に対
する色白効果、シミ、ソバカスの解消などの使用テスト
の2点から判定した。
The whitening effect is based on the so-called tyrosinase activity inhibition rate, which is the rate at which Dopa inhibits the action of tyrosinase, which produces the black-brown pigment melanin, and the skin whitening effect of cumulative application, and the results of usage tests such as the elimination of age spots and freckles. Judgment was made from two points.

ロシ −ゼ L−ドーパを基質としチロシナーゼを25℃、1.5分
間作用させ生成するメラニン中間体であるドーパクロム
を475n諷で、吸光光度計により測定する方法で行っ
た。反応液組成、判定方法を以下に示す。
Dopachrome, a melanin intermediate produced by using rosinase L-dopa as a substrate and acting on tyrosinase at 25° C. for 1.5 minutes, was measured using an absorptiometer at 475 nm. The reaction solution composition and determination method are shown below.

(反応液組成) L−dopa  0.5mg/ml         
          O,5Ill  。
(Reaction liquid composition) L-dopa 0.5mg/ml
O,5Ill.

リン酸緩衝液(pH6,8)        0.9 
ml試料溶wf、0.05yal チロシナーゼ(マツシュルーム)    0.05ml
(log/ml)   (500unit/+sl)(
判定) 0:チロシナーゼ阻害率      70駕以上0 :
     /J           5O−70XΔ
:     n           20 =50駕
×、     、、            20駕以
下による (試験方法) 色黒、しみ、そばかす等に悩む、被試験者、1群20名
として、1つの試、料ローションを朝夕、3ケ月間、毎
日顔面に塗布し、3ケ月目にモの美白効果を調べた。
Phosphate buffer (pH6,8) 0.9
ml sample solution wf, 0.05yal Tyrosinase (pine mushroom) 0.05ml
(log/ml) (500unit/+sl)(
Judgment) 0: Tyrosinase inhibition rate 70 or more 0:
/J 5O-70XΔ
: n 20 = 50 pieces x 20 pieces or less (Test method) One group of 20 test subjects suffering from dark skin, spots, freckles, etc., applied the lotion in the morning and evening for 3 months. It was applied to the face every day, and its whitening effect was examined after 3 months.

(判定基準) 著  効:色素沈着がほとんど目立たなくなった。(Judgment criteria) Author: Effect: Pigmentation is almost invisible.

有  効:非常にうずくなった。Effective: Very tingling.

やや有効:ややうずくなった。Slightly effective: Slightly tingling.

無  効:変化無し く判定) 0:被試験者のうち著効、有効の示す割合(有効率)が
80駕以上の場合 ○:     〃 (有効率)が50−80駕の場合 ×:〃 (有効率)が50z以下の場合 チロシナーゼ活性阻害について次のような生薬について
行った。すなわちサポニンを主成分とするニンジン、セ
イヨウキズタ、マロニエ、の抽出物、またタンニンを主
成分とするハマメリス、カミツレ、西洋ノコギリ草の抽
出物およびベルベリンを主成分とするオウバクの抽出物
それにヘチマの液汁について行った。その結果ヘチマの
液汁、ハマメリス、カミツレ、西洋ノコギリ草の抽出物
は高いチロシナーゼ活性阻害効果を示すことがわかった
。ざらにヘチマの液汁、へマメリス、オウバクについて
これらとL−アスコルビン酸とを組合せた場合、ヘチマ
抽出物についてはそのチロシナーゼ活性阻害効果は増強
されることを見い出し本発明を完成するにいたった。
Ineffective: Judging as no change) 0: If the percentage of test subjects who are markedly effective or effective (effective rate) is 80 or more ○: If (effective rate) is 50-80 ×: ( If the efficacy rate) was 50z or less, the following herbal medicines were tested for inhibition of tyrosinase activity. In other words, extracts of carrot, ivy, and horse chestnut containing saponin as the main ingredient; extracts of Hamamelis, chamomile, and sawweed containing tannin as the main ingredient; extracts of Auronicum oleracea containing berberine as the main ingredient; and loofah sap. I followed him. As a result, it was found that extracts of loofah sap, hamamelis, chamomile, and yarrow showed a high inhibitory effect on tyrosinase activity. It was discovered that the tyrosinase activity inhibitory effect of loofah extract is enhanced when L-ascorbic acid is combined with loofah sap, loofah melis, and loofah melis, and the present invention has been completed.

次に実施例1、比較例1〜6についてのべる。Next, Example 1 and Comparative Examples 1 to 6 will be described.

表1の配合組成よりなるローションを調整し、そのチロ
シナーゼ活性阻害効果および累積塗布による美白効果に
ついて調べた。
A lotion having the composition shown in Table 1 was prepared, and its tyrosinase activity inhibiting effect and skin whitening effect upon cumulative application were investigated.

製法は以下の方法で調整した。即ち95%エチルアルコ
ール10gに、POE(20)ラウリルエーテル0.5
gおよび香料を混合し、次いでこの中にあらかじめグリ
セリン2gとプロピレングリコール1gと、クエン酸0
.2g、 L−アスコルビン酸またはそのエステル及び
ヘチマの液汁とを加え、ざらに、蒸留水を全重量が10
0gになるように必要量を添加し混合して調整した。
The manufacturing method was adjusted as follows. That is, 0.5 g of POE (20) lauryl ether to 10 g of 95% ethyl alcohol.
g and fragrance, and then add 2 g of glycerin, 1 g of propylene glycol, and 0 citric acid in advance.
.. Add 2 g of L-ascorbic acid or its ester and loofah juice, add distilled water to a colander until the total weight is 10
The required amount was added and mixed to adjust the amount to 0g.

(以下余白) 表1 表2 表1から明らかなように、本発明の化粧料は美白効果に
優れる新規な化粧料である。
(The following is a blank space) Table 1 Table 2 As is clear from Table 1, the cosmetic of the present invention is a novel cosmetic with excellent whitening effects.

実施例2  乳液 次の処方に従い、常法により乳液を製造した。Example 2 Emulsion A milky lotion was produced by a conventional method according to the following recipe.

ステアリン酸            2.0セタノー
ル             1.0ワセリン    
          3゜0ラノリンアルコール   
      2.0流動パラフイン         
  8.0スクワラン             3.
0エス力ロール507           2.0ア
スコルビン酸−2−硫酸Ha       0.1ヘチ
マの液汁            o、ooosPOE
(10モル)モノオレート       2゜5トリエ
タノールアミン        1.0プロピレングリ
コール        5.0防腐剤        
       適量香料              
  適量蒸留水               残余実
施例3  栄養クリーム 次の処方に従い、常法により栄養クリームを製造した。
Stearic acid 2.0 Cetanol 1.0 Vaseline
3゜0 lanolin alcohol
2.0 liquid paraffin
8.0 Squalane 3.
0 Esriki Roll 507 2.0 Ascorbic acid-2-sulfuric acid Ha 0.1 Loofah juice o,ooosPOE
(10 mol) Monooleate 2゜5 Triethanolamine 1.0 Propylene Glycol 5.0 Preservative
Appropriate amount of fragrance
Appropriate amount of distilled water Remaining Example 3 Nutritional Cream A nutritional cream was produced by a conventional method according to the following formulation.

ステアリン酸              2.0ステ
アリルアルコール         7.0還元ラノリ
ン              2.0スクワラン  
             5.0オクチルドテカノー
ル          6.0P、0.E (25モル
)セチルエーテル                 
    3.0親油型千ノステアリン酸グリtイン  
                 2.0防腐剤  
               適量香料      
            適量プロピレングリコール 
         5.0゜アスコルビン酸タリン酸エ
ステル                      
0゜3アスコルビン酸ジオレート0.2 ヘチマの液汁             3.0蒸留水
                残余実施例4  パ
ック 次の処方に従い、常法によりパックを製造した。
Stearic acid 2.0 Stearyl alcohol 7.0 Reduced lanolin 2.0 Squalane
5.0 Octyldotecanol 6.0P, 0. E (25 mol) cetyl ether
3.0 Lipophilic Glytin Stearate
2.0 preservative
Appropriate amount of fragrance
Appropriate amount of propylene glycol
5.0゜Ascorbic acid talate ester
0.3 Ascorbic acid diolate 0.2 Luffa sap 3.0 Distilled water Remaining Example 4 Pack A pack was manufactured by a conventional method according to the following recipe.

カオリン               69.6タル
ク                19.Oプロピレ
ングリコール          5.0酢酸カルシウ
ム             0.01尿素     
             0.5アスコルビン酸モノ
パルミテート5.0ヘチマの液汁          
   0.5香料                 
 0.39実施例5  化粧水 次の処方に従い、常法によりパックを製造した。
Kaolin 69.6 Talc 19. O Propylene glycol 5.0 Calcium acetate 0.01 Urea
0.5 Ascorbic acid monopalmitate 5.0 Luffa liquid juice
0.5 fragrance
0.39 Example 5 Lotion A pack was manufactured by a conventional method according to the following formulation.

エタノール              15.0P、
0.E(20モル)オレイんアんコールエーテル   
           0.82−ヒドロキシ−4−メ
トキシペンツフェノン               
   0.1クエン酸               
 0.05クエン酸ソーダ             
0.01L−アスコルビン酸          0.
05ヘチマの液汁             0.05
グリセリン              5・0防腐剤
                適量香料     
            適量蒸留水        
        残余実施例2〜5より得られた化粧料
は、チロシナーゼ活性阻害効果に優れ、また累積塗布に
よる美白効果に優れていた。
Ethanol 15.0P,
0. E (20 moles) oleic encore ether
0.82-hydroxy-4-methoxypentuphenone
0.1 citric acid
0.05 Sodium citrate
0.01L-ascorbic acid 0.
05 Loofah juice 0.05
Glycerin 5.0 Preservative Appropriate amount of fragrance
Appropriate amount of distilled water
The cosmetics obtained from the remaining Examples 2 to 5 had excellent tyrosinase activity inhibition effects and also excellent whitening effects when applied cumulatively.

Claims (1)

【特許請求の範囲】[Claims] L−アスコルビン酸およびそのエステルよりなる群から
選ばれた一種または二種以上と、ヘチマの液汁とを含有
することを特徴とする化粧料。
A cosmetic comprising one or more selected from the group consisting of L-ascorbic acid and its esters and loofah sap.
JP60035595A 1985-02-25 1985-02-25 Cosmetic Granted JPS61194008A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60035595A JPS61194008A (en) 1985-02-25 1985-02-25 Cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60035595A JPS61194008A (en) 1985-02-25 1985-02-25 Cosmetic

Publications (2)

Publication Number Publication Date
JPS61194008A true JPS61194008A (en) 1986-08-28
JPH0118044B2 JPH0118044B2 (en) 1989-04-03

Family

ID=12446152

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60035595A Granted JPS61194008A (en) 1985-02-25 1985-02-25 Cosmetic

Country Status (1)

Country Link
JP (1) JPS61194008A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0429919A (en) * 1990-05-25 1992-01-31 Sunstar Inc Moisture-retaining cosmetic
JPH0436215A (en) * 1990-05-29 1992-02-06 Sunstar Inc Cosmetic having antiinflammatory property
JPH07258060A (en) * 1992-03-06 1995-10-09 Pacific Corp Skin whitening patch
KR20020088004A (en) * 2001-05-07 2002-11-25 박종문 An toilet composition for protecting and combating blemishes and aging of the skin
JP2006273809A (en) * 2005-03-30 2006-10-12 Naris Cosmetics Co Ltd Vegetable trypsin inhibitor
JP2018027917A (en) * 2016-08-18 2018-02-22 森永製菓株式会社 METHOD OF STABILIZING GLUCOSE p-COUMARIC ACID GLYCOSIDE, AND METHOD OF PRODUCING GLUCOSE p-COUMARIC ACID GLYCOSIDE SOLUTION USING THE SAME

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0429919A (en) * 1990-05-25 1992-01-31 Sunstar Inc Moisture-retaining cosmetic
JPH0436215A (en) * 1990-05-29 1992-02-06 Sunstar Inc Cosmetic having antiinflammatory property
JPH07258060A (en) * 1992-03-06 1995-10-09 Pacific Corp Skin whitening patch
KR20020088004A (en) * 2001-05-07 2002-11-25 박종문 An toilet composition for protecting and combating blemishes and aging of the skin
JP2006273809A (en) * 2005-03-30 2006-10-12 Naris Cosmetics Co Ltd Vegetable trypsin inhibitor
JP2018027917A (en) * 2016-08-18 2018-02-22 森永製菓株式会社 METHOD OF STABILIZING GLUCOSE p-COUMARIC ACID GLYCOSIDE, AND METHOD OF PRODUCING GLUCOSE p-COUMARIC ACID GLYCOSIDE SOLUTION USING THE SAME

Also Published As

Publication number Publication date
JPH0118044B2 (en) 1989-04-03

Similar Documents

Publication Publication Date Title
US5747006A (en) Skin whitener composition containing acerola cherry fermentate
US10016356B2 (en) Sebum secretion inhibitory agent
GB2287405A (en) Skin whitening compositions containing glycyrrhiza extracts
JPH04342519A (en) Skin cosmetic
JPH03236322A (en) Skin drug for external use
JP2903240B2 (en) External preparation for skin
JP2000169329A (en) Cosmetic composition
JPS61194008A (en) Cosmetic
JPH09301880A (en) Preparation for external use for skin
JPH0533683B2 (en)
JPH10279428A (en) Cosmetic
JP2002370962A (en) Bleaching preparation and cosmetic for preventing and improving aging of skin
JPH07258063A (en) External preparation for skin
JP2565516B2 (en) Topical skin
JPH01283208A (en) Beautifying cosmetic
JPH09255551A (en) Skin preparation for external use
JPH03200708A (en) Dermal external agent
JP2000256175A (en) Cosmetic composition
JPS60188306A (en) Cosmetic
KR102471312B1 (en) Cosmetic composition that protects skin from fine dust, including Nim Tree leaf extract
JP2002234828A (en) Skin whitening cosmetic preparation
KR100364314B1 (en) Use of unfermented honey as a depigmenting agent
JPH04356416A (en) Skin cosmetic
WO2005084613A1 (en) Skin preparation for external use
JP2000256174A (en) Cosmetic composition

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees